Abstract 5399: Growth inhibition, cytotoxicity and signaling studies of PI3K & MEK inhibitor combinations in colorectal carcinoma cell linesEmma J. Cox, David R. Newell, Suzanne Kyle et al.|Cancer Research|2010Cited by 0
60 Pre-clinical evaluation of combinations of PI3K & MEK inhibitors in colorectal carcinoma cell linesEmma J. Cox, David R. Newell, Gary Beale et al.|European Journal of Cancer Supplements|2010Cited by 0